Estrogen receptor status in inflammatory breast carcinoma

Harold Harvey, Allan Lipton, Bellarmine V. Lawrence, Deborah S. White, Samuel A. Wells, George Blumenschein, David Lee

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.

Original languageEnglish (US)
Pages (from-to)42-44
Number of pages3
JournalJournal of Surgical Oncology
Volume21
Issue number1
DOIs
StatePublished - Sep 1982

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Estrogen receptor status in inflammatory breast carcinoma'. Together they form a unique fingerprint.

Cite this